Skip to main content
. 2019 Mar 5;18:1534735419827079. doi: 10.1177/1534735419827079

Figure 2.

Figure 2.

Kaplan-Meier curves of OS in patients with advanced lung adenocarcinoma treated with first-line EGFR-TKIs according to TCM usage during the follow-up period from the study cohort (A) and matched cohort (B) and PFS in patients with advanced lung adenocarcinoma treated with first-line EGFR-TKIs according to TCM usage during the follow-up period from the study cohort (C) and the matched cohort (D). Abbreviations: EGFR, epidermal growth factor receptor; OS, overall survival; PFS, progression-free survival; TCM, traditional Chinese medicine; TKI, tyrosine kinase inhibitor.